Sub-Perception Neuromodulation Sequencing for Faster Pain Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional neuromodulation therapies, such as Spinal Cord Stimulation (SCS), often cause paresthesia, an uncomfortable side-effect, and have slow wash-in transition times, complicating the evaluation of therapeutic effectiveness and requiring frequent programming adjustments due to lead movement.

Innovation Solution

A neuromodulation system that delivers both fast-acting and slow-acting sub-perception neuromodulation therapies, with wash-in transition periods of less than a first time duration and more than a second time duration, respectively, to provide effective pain relief without paresthesia and reduce lead movement sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional SCS therapy is used to maximize stimulation of DC fibers for pain relief, then pain relief is improved, but paresthesia sensation occurs which is uncomfortable for patients

Engineering Contradiction:
Improvepain relief effectivenessVSAvoidparesthesia sensation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the stimulation parameters by delivering electrical pulses at frequencies between 1 Hz and 100 Hz with pulse widths between 100 microseconds and 1 second, and amplitudes below the paresthesia threshold. This parameter optimization allows activation of DC fibers for pain relief while avoiding the uncomfortable paresthesia sensation that occurs at higher amplitudes.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If sub-perception therapy is used to avoid paresthesia, then patient comfort is improved, but the wash-in transition time becomes excessively long complicating evaluation

Engineering Contradiction:
Improveparesthesia sensationVSAvoidwash-in transition time
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The patent employs dynamic parameter adjustment where stimulation amplitude, pulse width, and frequency are varied over time to achieve sub-perception therapy without excessive wash-in time. The system adapts parameters based on patient response and therapeutic goals, allowing faster onset of effect while maintaining comfort.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent uses periodic electrical pulse delivery with specific frequency ranges (1-100 Hz) to achieve therapeutic effects. The periodic stimulation pattern allows for controlled activation of neural pathways while managing the wash-in transition time through rhythmic delivery cycles.

Inventive Principle:
Principle #19Periodic action

3Reliability

If high amplitude stimulation is used to ensure therapeutic effectiveness, then pain relief reliability is improved, but sensitivity to lead movement increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidsensitivity to lead movement
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent optimizes stimulation parameters to use amplitudes that are effective for pain relief but remain below the paresthesia threshold. By carefully selecting amplitude, pulse width, and frequency combinations, the system achieves therapeutic effectiveness while reducing the intensity that would amplify sensitivity to lead position changes.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12605550B2Therapy implemented using different sub-perception neuromodulation types
Publication Date: 2026.04.21 BOSTON SCI NEUROMODULATION CORP
  • US12605550B2 patent drawing
  • US12605550B2 patent drawing
  • US12605550B2 patent drawing

AI summary

A neuromodulation system for use with electrodes to modulate a volume of neural tissue may include a waveform generator and a controller. The waveform generator may be configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a neuromodulation therapy. The controller may be configured to use a program to control the waveform generator to deliver a neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation. The fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.